Intranasal Peptide Stability and Storage Guidelines

Peptide stability is a critical consideration for intranasal formulations, where the aqueous environment presents unique degradation challenges. This article reviews degradation pathways and evidence-based storage guidelines for intranasal peptide preparations.

Degradation Pathways

Peptides in aqueous solution degrade through several mechanisms:

Hydrolysis

Water can cleave peptide bonds, particularly at labile residues. Asparagine and glutamine residues are susceptible to deamidation, while serine and threonine can undergo O-glycosidic bond cleavage. Hydrolysis rates increase at extreme pH values and elevated temperatures.

Oxidation

Methionine, cysteine, tryptophan, and histidine residues are oxidation-prone. Oxidation can be accelerated by light exposure, metal ions, and dissolved oxygen. Antioxidants (e.g., methionine as a sacrificial substrate) and nitrogen overlays can mitigate oxidative degradation.

Aggregation

Peptides can self-associate into dimers, oligomers, or higher-order aggregates. Aggregation is promoted by high concentration, elevated temperature, and mechanical stress (shaking). Aggregated peptides may lose biological activity and can cause immunogenicity concerns.

Racemization

Amino acid residues can undergo racemization (conversion from L- to D-configuration), particularly at elevated temperatures and extreme pH. Racemized peptides may have reduced or altered biological activity.

Lyophilized vs. Reconstituted Stability

Lyophilized (freeze-dried) peptides are far more stable than their reconstituted counterparts. In the dry state, hydrolysis and aggregation rates are dramatically reduced. Lyophilized peptides stored at -20°C can remain stable for 12-24 months or longer.

Reconstituted peptides in aqueous solution are significantly less stable. The reconstitution process itself introduces water, the primary driver of hydrolytic degradation. Reconstituted peptides stored at 2-8°C typically maintain acceptable stability for 4-6 weeks.

Storage Temperature Guidelines

• •-20°C (freezer) — optimal for long-term storage of both lyophilized and reconstituted peptides
• •2-8°C (refrigerator) — acceptable for short-to-medium term storage of reconstituted solutions
• •Room temperature — not recommended for long-term storage; acceptable only for short-term transit

Light and Moisture Protection

Peptide preparations should be protected from:

• •UV light — accelerates oxidation and photodegradation; use amber vials or light-blocking containers
• •Moisture — critical for lyophilized peptides; use desiccant packs and avoid frequent opening
• •Freeze-thaw cycles — repeated freezing and thawing degrades peptides; aliquot reconstituted solutions into single-use volumes

Intranasal-Specific Considerations

Intranasal formulations face unique stability challenges:

• •Aqueous format — inherently less stable than lyophilized powder
• •Preservative compatibility — preservatives may interact with peptides over time
• •Device interactions — some spray device materials can adsorb peptides or leach contaminants

Semax and Selank intranasal solutions should be stored according to manufacturer guidelines, typically refrigerated and protected from light. BPC-157 for intranasal research is often prepared from lyophilized powder immediately before use to maximize stability.

Research Use Only. Not for human consumption. All referenced compounds are intended for laboratory research purposes only.